Modelling in Health Economic Evaluation
Authors:
- 1 May 2000
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (5) , 445-459
Abstract
This paper itemises the current and developing roles of modelling in health economic evaluation and discusses its value in each role. We begin by noting the emptiness of the dichotomy that some...Keywords
This publication has 21 references indexed in Scilit:
- Pharmacoeconomic Evaluation in the Real WorldPharmacoEconomics, 1999
- Methodological Hurdles in Conducting Pharmacoeconomic AnalysesPharmacoEconomics, 1999
- Provider and customer expectations of successful simulation projectsJournal of the Operational Research Society, 1998
- An economic approach to clinical trial design and research priority-settingHealth Economics, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994
- Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysisHealth Economics, 1994
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- Orders of Validation in Mathematical ModellingJournal of the Operational Research Society, 1990
- Using cost‐effectiveness analysis to improve the efficiency of allocating funds to clinical trialsStatistics in Medicine, 1990